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Innovations
A new breed ofantimicrobial polymers is at
work waylaying the growth of potentially
harmful bacteria, molds, and fungi in an
array of industrial, institutional, and con-
sumer products. Developed by a trio of
North Carolina biomedical engineers at
Microban Products Company, the antimi-
crobial additives go into the products and
materials they protect during the manufac-
turing process, yielding an inherently effec-
tive defense against the growth of
microbes-and a protection that won't
wash offor wear away. Independent labora-
tory tests have consistently shown dramatic
reductions in microbial populations present
on materials manufactured with Microban.
A large number and variety of prod-
ucts now incorporate Microban
including kitchen cutting boards,
dental instrument trays, surgical
incise drapes, socks, bedding,
food-service wipes, and even
concrete and industrial
drains. The list is growing,
thanks to the demand by
companies seeking to infuse
antimicrobial properties into
their products and the public's blossoming
awareness of the ravages these omnipresent
microbes can inflict on the human body.
The Quest for Cleanliness
The quest for cleanliness is hardly new.
During World War I, the Germans discov-
ered that antimicrobial treatments for uni-
forms worn by soldiers engaged in trench







Topically applied finishes (for example
quaternary ammonium compounds in sili-
cone carriers) eventually wear off. Ironically,
the same kind of "wear and tear" that
erodes these coatings and renders them ulti-
mately ineffective actually triggers the
release of more Microban molecules at the
surface of the material. The activation of
these molecules from abrasion yields perma-
nent effectiveness over the product's life-
time.
The development of Microban's
antimicrobial polymers evolved over a
period ofseveral years. Since their days at
Bristol-Myers' medical products division,
Microban President Glenn Cueman and
his cofounders Henry Richbourg and
Barnwell Ramsey had product develop-
ment in their blood. They also understood
the critical need for clean medical environ-
ments. In 1987, they left Bristol-Myers-
each ofthem with a 15-year tenure behind
them-to form Clinitex Corporation, the
forerunner of Microban. Clinitex pro-
duced orthopedic and specialty medical
devices and related products for hospitals
and long-term care facilities, as well as for
in-home medical care.
"Back in the '70s and '80s, we were
constantly looking for a way to improve
medical devices," Cueman recalls.
"Control of microorganisms was tops on
that list." For years, the medical commu-
nity relied on steam, gas, or radiation to
kill harmful microorganisms. And even
with procedures like iodine scrubs and
alcohol preps, there was always the fear
that a patient might leave the hospital with
an illness worse than the one he or she had
coming in, Cueman says. The whole envi-
ronment poses a threat to surgery patients,
from surgical drapes that harbor germs to
the heating and air-conditioning ducts
that spew air contaminated by colonies of
molds and mildew.
"That was where we began our quest,"
says Cueman. He and his colleagues want-
ed to make a material that would be inher-
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ently resistant to microbial contamination.
They knew that heavy metals such as
arsenic, copper, zinc, and silver were
microbe-resistant and could be extruded
during the polymer manufacturing process,
but that such materials were often unsuit-
able or unsafe for human contact.
Instead, they sought to find
a compound that "was
well-documented for
contact with human
skin," Cueman says, then
to encapsulate it and intro-




Just how these molecules
defeat pathogenic microorgan-
isms including Escherichia coli
and Salmonella enteritidis is a
small miracle. Using the Microban process,
synthetic fibers or plastics incorporate pel-
lets encapsulating high concentrations of
antimicrobial additives. These additives
differ according to the chemical makeup of
the product for which the pellets are even-
tually destined. According to Cueman, the
'~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Power pellets. Inlaboratorytestst bacteria-free zones~
surround antimicrobial pellets (red and yellow).~~~~
The front lines. New products containing antimicrobia
include children's chairs, mattress pads, and counterto
development] process for each type of
material being made," Cueman says. For
example, when the eventual product is
socks, "The manufacturer will solubilize
our product, then repolymerize it during
the fiber extrusion process," Cueman
explains. "Basically, we're a custom formu-
lator. We have a database that shows how
much [of the additive] to use for each
application," he says.
For example, a cutting board with the
Microban additive is formed from polyeth-
ylene pellets one-tenth of an inch square.
Except for containing the antimicrobial
ingredient, Microban pellets are the same
color and composition as the basic material,
Cueman explains, and "become intimately
blended, part of the product's molecular
structure." The synthetic additive retains its
antimicrobial properties for the life of the
fabric or plastic into which it is formulated,
and it is not water-soluble. According to
independent tests by several laboratories,
the additives are noncarcinogenic and non-
allergenic to the skin. Depending on the
application, the additives also bear the
stamp of FDA approval or EPA registra-
tion.
The trick to the Microban ingredient's
function is introducing it into the poly-
mer's amorphous phase. "We don't want it
to chemically react or cross-link," says
Cueman. Because these molecules exist in
the amorphous phase, they are free to
migrate within the polymer, and do so
when the product's surface is abraded-
when, for example, a cut-
!2 ting board, sock, or mat-
_ tress pad is used orwashed.
The additive remains
twithin the interstitial spaces
ofthe fiber or plastic's poly-
meric backbone. Suspended
there, the additive is free to




due in part to the low con-
centration of Microban
additive dispersed through-
out the material, with sur-
_ face concentrations measured
in micrograms per gram. Even
though the Microban additives
are dispersed into lower con-
centrations in the finished
products, thousands of tests
have shown them to be effec-
tive on a number of microor-
ganisms, including gram-posi-
31 polymers tive and gram-negative bacte-
ips. ria, ammonia-producing bacte-
ria, fungi, dermatophytes, resi-
dent skin bacteria, molds, and yeasts. And,
says Cueman, the product is both safe and
permanent.
The Microban additives lie in ambush,
waiting for unsuspecting microorganisms,
then rupture their cytoplasmic membrane.
This in turn releases a leakage oflow-mole-
cular-weight cellular material, which pre-
vents the uptake ofamino acids essential to
further cellular growth. Like pins patiently
poised to pierce a falling balloon,
Microban pellets penetrate the thin cellular
walls of the tiniest microorganisms.
Thicker cellwalls-such as those ofhuman
cells and insect cells, for example-remain
impervious to this cellular invasion. So,
while the antimicrobial additive is effective
on bacteria and fungi, it is harmless to
higher life forms. And, once ingested, the
additive is quickly eliminated from the
human body.
Because Microban operates as a cell-
wall penetrator, it is difficult for microor-
ganisms to build up an immunity to it, a
noteworthy advantage in an age of drug-
resistant bacteria. The additive has not
only inhibited growth of methicillin-resis-
tant Staphylococcus aureus, it has also
shown similar effectiveness on four other
strains of Staphylococcus aureus. Microban
has also been effective with at least two
strains of Staphylococcus epidermis, as well
as two strains ofEnterococcus faecalis.
ExtensiveTesting
Microban Products Company employs a
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number of laboratories to run extensive
tests on the effectiveness of its antimicro-
bial additives. Tests include the Kirby-
Bauer Antimicrobial Susceptibility Test
and AATCC Method 147-1993-both of
which generate qualitative data gathered by
observing what happens when the
Microban product comes into contact with
a bacterial or fungal culture in a petri
dish-as well as AATCC Method 100-
1993, which generates quantitative data
collected at intervals and shows a reduction
in microbial count on the subject sample.
Various Microban applications are rou-
tinely tested on representative microorgan-
isms including Staphylococcus aureus,
Esherichia coli, Klebsiella pneumoniae,
Proteus vulgaris, and Trichophyton menta-
grophytes. In these tests, ifa sample shows a
decrease in microbes greater than 90%, the
sample is deemed to have shown antimi-
crobial activity. If testers see inactivity on
the sample or observe increased microbial
growth, then the sample is determined to
be ineffective.
North American Science Associates,
Inc. in Kennesaw, Georgia, is one labora-
tory that has run thousands of tests on
products containing Microban. "The addi-
tive is certainly effective against quite a few
microorganisms," says Antimicrobials
Section Manager James Kautz.
"Microban's products seem to be very con-
sistent in their effectiveness, which proba-
bly has to do with the amount of research
and testing they've done."
Other tests are being done to test
Microban's effectiveness in the "real-
world" environment. Greg McNiece,
director of research and development at
the Greenville Hospital System in
Greenville, South Carolina, is responsible
for testing a number of products contain-
ing Microban, including drains and con-
crete flooring in hospital decontamination
rooms, acrylic flooring, countertops in
food preparation areas, carpeting, and sur-
gical drapes.
When a polymer chemist from
Microban first approached McNiece with
antimicrobial products to try, McNiece
admits he was "a little skeptical about
bringing [the product] into the health care
setting," fearing that the hospital would
somehow end up with a "mutated, resis-
tant strain ofbacteria." His concerns were
allayed when he found that Microban
offered a synthetic polymer additive. "This
is a passive system that doesn't seek the
cell, but sits there like little daggers waiting
to burst the bubble," McNiece explains.
"It's not transferrable from one cell to
another, but locked into the chains of the
polymer. That's a safety net right there."
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The Question ofDisease Control
Cueman cautions against viewing
Microban's antimicrobial technology as a
panacea for ridding the world of harmful
germs and the diseases they cause. "We
paint a very realistic picture," he says,
"which does not mean that the [product
containing Microban] is sterile, but is
much more resistant." Manufacturers must
be diligent about labeling, he adds, and
careful not to mislead product users, espe-
cially now that Microban is showing up in
an ever-growing list of consumer products
including high-chair trays, athletic socks,
and mattress pads.
Cueman says that some ofthe compa-
ny's customers are now doing long-term
studies to explore Microban's effectiveness
in inhibiting the transmission ofinfectious
diseases. Microban's impressive laboratory
results, Cueman says, "are an indicator
that you're going to reduce the chance of
infection. If you substantially reduce the
overall numbers, then that will lead to less
cross-contamination."
McNiece agrees that the reduction of
microbial populations makes a difference,
especially in the hospital setting, where
cleanliness is a top health and safety con-
cern. "This [technology] will reduce the
bioburden to the point where we don't
have other microorganisms coming in to
feed on existing microbial populations,"
McNiece says. The bottom line, according
to McNiece, is protecting the patient at
two levels: through improving the the
physical environment and through keeping
any product that touches the patient as
clean as possible.
What LiesAhead
McNiece hopes to expand the use and test-
ing of antimicrobial products into clinics,
physicians' offices, and long-term care
facilities, where control ofmicroorganisms
and the odors they cause is a real concern.
"We're gearing up to build a multimillion-
dollar family medical center that we hope
will be a test site for concrete with
Microban," he says. "Halfthe concrete will
be normal, and the other half will be
Microban concrete," he explains.
Microban concrete is made by incorporat-
ing antimicrobial fibers an eighth of an
inch long into the concrete.
McNiece envisions a whole team of
products containing Microban such as
steps, handrails, toilet seats, trash recepta-
cles, and tile, all working together in a
physician's office, for example, to slow the
production of harmful microbes. "Our
infection control people are very excited
about these antimicrobial products," he
says.
The appeal of antimicrobial products
across a broad spectrum of the market in
the United States and worldwide, along
with a healthy dose ofentrepreneurial spir-
it at Microban, keeps the company's
research and development staffcontinually
probing new applications and product pos-
sibilities.
"We've pretty much exhausted most of
the polymers," Cueman says. "Now we're
looking into natural fibers-ways to treat
cotton after it is produced." And, he adds,
the company has an advanced coating
technology in the works as well. "We're
working on ways we can apply permanent
coatings to things like ceramics, glassware,
and tile."
The companywill continue its research
as a virtual loner in its field. Other compa-
nies are working in the field of antimicro-
bials in the industrial setting and with top-
ically applied products, but Microban is
essentially the only company doing so
"with proven organic materials similar to
those used in soaps and deodorants which
are built into the polymers," Cueman
claims. He also plans to take several busi-
ness ventures into Japan, a country that
has a long history of preoccupation with
cleanliness.
While the jury is still out on
Microban's efficacy as a direct disease-
fighter, there's no question that antimicro-
bial products are here to stay. As long as
there are germs, there will no doubt be a
demand for any proven method that
promises to make the indoors a cleaner
place.
Jennifer Medlin
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